AGATA

Biomarker
Program

SOLTI-DBMS

SOLTI Molecular screening platform: a Pilot Study to implement personalized therapy for patients with advanced or metastatic breast cancer (MBC).

Status

Tumour subtype:

Scenario

SPONSOR

SOLTI

COLLABORATORS

PRINCIPAL INVESTIGATORS

Eva Mª Ciruelos Gil , MD, PhD (Hospital 12 de Octubre, Madrid)
Sònia Pernas Simón, MD ICO (L’Hospitalet, Barcelona)

Sites

Link to clinicaltrials.gov / EudraCT